Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Monisha N Banerjee"'
Autor:
Angela C Rieger, Bryon A Tompkins, Makoto Natsumeda, Victoria Florea, Monisha N Banerjee, Jose Rodriguez, Marcos Rosado, Valeria Porras, Krystalenia Valasaki, Lauro M Takeuchi, Kevin Collon, Sohil Desai, Michael A Bellio, Aisha Khan, Nilesh D Kashikar, Ana Marie Landin, Darrell V Hardin, Daniel A Rodriguez, Wayne Balkan, Joshua M Hare, Ivonne Hernandez Schulman
Publikováno v:
Stem Cells Translational Medicine. 11:59-72
Background Left ventricular hypertrophy and heart failure with preserved ejection fraction (HFpEF) are primary manifestations of the cardiorenal syndrome in patients with chronic kidney disease (CKD). Therapies that improve morbidity and mortality in
Autor:
Bryon A. Tompkins, Angela C. Rieger, Victoria Florea, Monisha N. Banerjee, Makoto Natsumeda, Evan D. Nigh, Ana Marie Landin, Gianna M. Rodriguez, Konstantinos E. Hatzistergos, Ivonne Hernandez Schulman, Joshua M. Hare
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 14 (2018)
Background Ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) differ in histopathology and prognosis. Although transendocardial delivery of mesenchymal stem cells is safe and provides cardiovascular benefits in both, a comparison of mesen
Externí odkaz:
https://doaj.org/article/f20646039bc24ed7a1aed7ff8eb84856
Autor:
Anthony Cahill, Eva M. Urrechaga, Stephen M. Cresse, Howard Lieberman, Monisha N. Banerjee, Alessia C. Cioci
Publikováno v:
Journal of Cardiac Surgery. 35:492-494
BACKGROUND Left ventricular assist device (LVAD) implantation is a lifesaving intervention in advanced heart failure. However, LVAD is not without complication. In this case, an inadvertent intraperitoneal driveline caused small bowel obstruction, su
Autor:
Lauro M Takeuchi, Angela C Castellanos, Monisha N. Banerjee, Aisha Khan, Wayne Balkan, Daniel A. Rodriguez, Ivonne Hernandez Schulman, Victoria Florea, Michell Bellio, Joshua M. Hare, Jose Rodriguez, Darrell Hardin, Marcos Rosado, Bryon A. Tompkins, Makoto Natsumeda, Kristalenia Valasaki, Sohil S. Desai
Publikováno v:
Circulation Research. 127
Background: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous condition involving multiple comorbidities. Phenotypic classification of HFpEF associated with chronic kidney disease (CKD) manifests worse outcomes, compared to ot
The ability of stem cell therapy to promote cardiac repair, albeit incomplete, represents a paradigm shift from current pharmacologic therapies that simply manage heart disease. However, choosing the right cell type has been a challenge. Bone marrow-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5506d4914f3336e84acdb2e1dfa61c6
https://doi.org/10.1016/b978-0-12-813706-2.00010-5
https://doi.org/10.1016/b978-0-12-813706-2.00010-5
Autor:
Louis Vincent, Vasileios Karantalis, Kevin Collon, Raul Mitrani, Samuel Golpanian, Bryon A. Tompkins, Ana Marie Landin, Ariel Wolf, Monisha N. Banerjee, Cristina Sanina, Wayne Balkan, Alan W. Heldman, Makoto Natsumeda, Victoria Florea, Kostas E. Hatzistergos, Julia Fritsch, Nilesh D. Kashikar, Ivonne Hernandez Schulman, Angela C. Rieger, Viky Y. Loescher, Jose Rodriguez, Luiza Bagno, Muzammil Mushtaq, Marcos Rosado, Anthony J. Kanelidis, Joshua M. Hare
Publikováno v:
Journal of the American College of Cardiology. 70:2504-2515
Background The combination of autologous mesenchymal stem cells (MSCs) and cardiac stem cells (CSCs) synergistically reduces scar size and improves cardiac function in ischemic cardiomyopathy. Whereas allogeneic (allo-)MSCs are immunoevasive, the cap
Publikováno v:
European Journal of Heart Failure. 19:1530-1533
Autor:
Aleksandra Leszczynska, Makoto Natsumeda, Elliott Eggan, Bryon A. Tompkins, Monisha N. Banerjee, Daniel A. Herzka, Virginia E. Bogdan, Robert G. Weiss, Gary Gerstenblith, Victoria Florea, Katherine C. Wu, Wayne Balkan, Kevin J. Mills, Steven P. Schulman, Gordon F. Tomaselli, Joshua M. Hare, Chao Wei Hwang, Jeffrey A. Brinker, Peter V. Johnston
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Prevention of adverse remodeling after myocardial infarction ( MI) is an important goal of stem cell therapy. Clinical trial results vary, however, and poor cell retention and survival after delivery likely limit the opportunity to exert b
Autor:
Gianna M. Rodriguez, Victoria Florea, Angela C. Rieger, Makoto Natsumeda, Monisha N. Banerjee, Joshua M. Hare, Ana Marie Landin, Evan Nigh, Konstantinos E. Hatzistergos, Ivonne Hernandez Schulman, Bryon A. Tompkins
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Ischemic cardiomyopathy ( ICM ) and dilated cardiomyopathy ( DCM ) differ in histopathology and prognosis. Although transendocardial delivery of mesenchymal stem cells is safe and provides cardiovascular benefits in both, a comparison of m
Publikováno v:
Circ Res
Given the rising prevalence of cardiovascular disease worldwide and the limited therapeutic options for severe heart failure, novel technologies that harness the regenerative capacity of the heart are sorely needed. The therapeutic use of stem cells